NTRB - Nutriband Inc

3.935
-0.085   -2.160%

Share volume: 21,693
Last Updated: 03-11-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$4.02
-0.08
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
43%
Profitability 35%
Dept financing 24%
Liquidity 74%
Performance 48%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.41%
1 Month
-3.08%
3 Months
-22.84%
6 Months
-44.97%
1 Year
-38.13%
2 Year
67.45%
Key data
Stock price
$3.94
P/E Ratio 
0.00
DAY RANGE
$3.64 - $4.10
EPS 
-$2.68
52 WEEK RANGE
$3.64 - $11.68
52 WEEK CHANGE
-$35.70
MARKET CAP 
75.068 M
YIELD 
N/A
SHARES OUTSTANDING 
12.175 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.70
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$16,309
AVERAGE 30 VOLUME 
$11,987
Company detail
CEO: Gareth R. Sheridan
Region: US
Website: nutriband.com
Employees: 10
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl system.

Recent news